Clindamycin Supplier-Buyer Network — Trade Flow Analysis

Name: Clindamycin Supplier-Buyer Trade Network Dataset — 527+ Indian Exporters, 17+ Importers, 144+ Countries (DGFT 2022–2026)
Creator: TransData Nexus
License: https://transdatanexus.com/terms
Keywords: Clindamycin supplier network, Clindamycin buyers, pharmaceutical export India, Clindamycin trade data

TransData Nexus

Clindamycin

India Pharmaceutical Trade Intelligence

$90.2M527 Suppliers144 CountriesHS 30042095

ExportsIndia → UNITED STATES60.9%India → KENYA5.1%

ImportsBELGIUM → India$14.3B FRANCE → India$32.3M

#1 Supplier: ENCUBE ETHICALS #1 Buyer: CARDINAL HEALTH

Who Supplies Clindamycin? Top Manufacturers & Buyers 2026 — ENCUBE ETHICALS PRIVATE LIMITED Leads | TransData Nexus | TransData Nexus

1ENCUBE ETHICALS PRIVATE LIMITED

ENCUBE ETHICALS PRIVATE LIMITED is the first-largest Clindamycin exporter from India, with a market share of 14.3% and a total export value of $12.9M across 291 shipments. Their average shipment value of $44.4K is above the market average of $12.5K, suggesting premium or bulk contract pricing.

ENCUBE ETHICALS PRIVATE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• CARDINAL HEALTH — $4.7M across 107 shipments (36.7% of this supplier's total exports)

• IPD, SC, USA — $4.6M across 104 shipments (35.8% of this supplier's total exports)

• AIM RX 3PL, LLC — $1.6M across 37 shipments (12.7% of this supplier's total exports)

• IPD, SC, USA — $1.1M across 24 shipments (8.2% of this supplier's total exports)

• MCKESSON THIRD PARTY — $854.6K across 19 shipments (6.6% of this supplier's total exports)

Key Insight: ENCUBE ETHICALS PRIVATE LIMITED's per-shipment value of $44.4K is 257% above the market average of $12.5K, consistent with large-order contracts or value-added formulations.

2AUROBINDO PHARMA LTD

AUROBINDO PHARMA LTD is the second-largest Clindamycin exporter from India, with a market share of 6.7% and a total export value of $6.1M across 188 shipments. Their average shipment value of $32.3K is above the market average of $12.5K, suggesting premium or bulk contract pricing.

AUROBINDO PHARMA LTD serves 5 named buyers in our database. AUROLOGISTICS LLC (AUROBINDO PHARMA is the dominant customer, accounting for 65.4% of this supplier's tracked business. Top customers include:

• AUROLOGISTICS LLC (AUROBINDO PHARMA — $4.0M across 123 shipments (65.4% of this supplier's total exports)

• AUROLOGISTICS LLC — $842.0K across 26 shipments (13.8% of this supplier's total exports)

• NORTHSTAR DISTRIBUTION CENTER 8912 — $488.7K across 15 shipments (8.0% of this supplier's total exports)

• AURO PHARMA INC — $408.2K across 13 shipments (6.7% of this supplier's total exports)

• AUROLOGISTICS LLC — $366.6K across 11 shipments (6.0% of this supplier's total exports)

Key Insight: AUROBINDO PHARMA LTD's per-shipment value of $32.3K is 160% above the market average of $12.5K, consistent with large-order contracts or value-added formulations.

3AUROBINDO PHARMA LIMITED

AUROBINDO PHARMA LIMITED is the third-largest Clindamycin exporter from India, with a market share of 6.2% and a total export value of $5.6M across 63 shipments. Their average shipment value of $89.2K is above the market average of $12.5K, suggesting premium or bulk contract pricing.

AUROBINDO PHARMA LIMITED serves 5 named buyers in our database. AUROLOGISTICS LLC AUROBINDO PHARM is the dominant customer, accounting for 67.4% of this supplier's tracked business. Top customers include:

• AUROLOGISTICS LLC AUROBINDO PHARM — $3.8M across 42 shipments (67.4% of this supplier's total exports)

• AUROLOGISTICS LLC — $701.3K across 8 shipments (12.5% of this supplier's total exports)

• AUROLOGISTICS LLC (AUROBINDO PHARMA — $423.5K across 5 shipments (7.5% of this supplier's total exports)

• AUROBINDO PHARMA USA — $383.8K across 4 shipments (6.8% of this supplier's total exports)

• AURO PHARMA INC — $326.7K across 4 shipments (5.8% of this supplier's total exports)

Key Insight: AUROBINDO PHARMA LIMITED's per-shipment value of $89.2K is 616% above the market average of $12.5K, consistent with large-order contracts or value-added formulations.

4MICRO LABS LIMITED

MICRO LABS LIMITED is the fourth-largest Clindamycin exporter from India, with a market share of 4.8% and a total export value of $4.3M across 93 shipments. Their average shipment value of $46.3K is above the market average of $12.5K, suggesting premium or bulk contract pricing.

MICRO LABS LIMITED serves 5 named buyers in our database. EVERSANA LIFE SCIENCE SERVICES LLC is the dominant customer, accounting for 56.1% of this supplier's tracked business. Top customers include:

• EVERSANA LIFE SCIENCE SERVICES LLC — $2.4M across 52 shipments (56.1% of this supplier's total exports)

• EVERSANA LIFE SCIENCE SERVICES LLC — $1.6M across 34 shipments (36.1% of this supplier's total exports)

• EVERSANA LIFE SCIENCE SERVICES LLC — $230.3K across 5 shipments (5.3% of this supplier's total exports)

• MICRO HEALTHCARE (PR — $55.7K across 1 shipments (1.3% of this supplier's total exports)

• BROWN AND BURK UK LI — $47.4K across 1 shipments (1.1% of this supplier's total exports)

Key Insight: MICRO LABS LIMITED's per-shipment value of $46.3K is 272% above the market average of $12.5K, consistent with large-order contracts or value-added formulations.

5BIOMATRIX HEALTHCARE PRIVATE LIMITED

BIOMATRIX HEALTHCARE PRIVATE LIMITED is the fifth-largest Clindamycin exporter from India, with a market share of 3.7% and a total export value of $3.4M across 62 shipments. Their average shipment value of $54.1K is above the market average of $12.5K, suggesting premium or bulk contract pricing.

BIOMATRIX HEALTHCARE PRIVATE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• UNIQUE PHARMA, — $1.6M across 30 shipments (48.1% of this supplier's total exports)

• UNICA FARMA, LDA. — $1.5M across 28 shipments (44.8% of this supplier's total exports)

• UNIQUE PHARMA, — $180.5K across 3 shipments (5.4% of this supplier's total exports)

• UNICA FARMA, LDA. — $33.4K across 1 shipments (1.0% of this supplier's total exports)

• ACE HEALTH CARE LDA — $23.7K across 0 shipments (0.7% of this supplier's total exports)

Key Insight: BIOMATRIX HEALTHCARE PRIVATE LIMITED's per-shipment value of $54.1K is 334% above the market average of $12.5K, consistent with large-order contracts or value-added formulations.

6GLENMARK PHARMACEUTICALS LIMITED

GLENMARK PHARMACEUTICALS LIMITED is the fifth-largest Clindamycin exporter from India, with a market share of 3.1% and a total export value of $2.8M across 199 shipments. Their average shipment value of $13.9K is above the market average of $12.5K, suggesting premium or bulk contract pricing.

GLENMARK PHARMACEUTICALS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• NORTHSTAR DISTRIBUTION CENTER 8912 — $870.6K across 63 shipments (31.5% of this supplier's total exports)

• GLENMARK PHARMACEUTICALS INC., USA — $721.7K across 52 shipments (26.1% of this supplier's total exports)

• NORTHSTAR DISTRIBUTION CENTER 8912 — $571.3K across 41 shipments (20.7% of this supplier's total exports)

• GLENMARK PHARMACEUTICALS INC., USA — $318.8K across 23 shipments (11.5% of this supplier's total exports)

• GLENMARK PHARMACEUTICALS INC., USA — $281.9K across 20 shipments (10.2% of this supplier's total exports)

Key Insight: GLENMARK PHARMACEUTICALS LIMITED's per-shipment value of $13.9K is 11% above the market average of $12.5K, consistent with large-order contracts or value-added formulations.

1United States

United States ranks as the first-largest destination for Clindamycin imports from India, with a total trade value of $55.0M across 688 shipments — representing a 60.9% share of all Clindamycin exports. The average shipment value of $79.9K is above the global average of $12.5K, indicating high-value procurement contracts or branded formulations. This market is served by 13 tracked buyers.

Named Clindamycin importers in United States: CARDINAL HEALTH is the largest buyer, accounting for 10.5% ($5.8M) of this market's total imports.

• CARDINAL HEALTH — $5.8M (10.5% of United States's total)

• EVERSANA LIFE SCIENCE SERVICES, LLC — $4.8M (8.7% of United States's total)

• IPD, SC, USA — $4.8M (8.7% of United States's total)

Key Insight: United States's per-shipment average of $79.9K (541% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

United States is a key market for Clindamycin imports from India.

Primary Market

Secondary Market

2Kenya

Kenya ranks as the second-largest destination for Clindamycin imports from India, with a total trade value of $4.6M across 19 shipments — representing a 5.1% share of all Clindamycin exports. The average shipment value of $240.5K is above the global average of $12.5K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.

Named Clindamycin importers in Kenya: SYNERMED PHARMACEUTICALS (KENYA)LTD is the largest buyer, accounting for 58.1% ($2.7M) of this market's total imports.

• SYNERMED PHARMACEUTICALS (KENYA)LTD — $2.7M (58.1% of Kenya's total)

• WESSEX PHARMACEUTICALS LIMITED, — $1.2M (27.3% of Kenya's total)

Key Insight: Kenya's per-shipment average of $240.5K (1830% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Kenya is a key market for Clindamycin imports from India.

Primary Market

Secondary Market

3Philippines

Philippines ranks as the third-largest destination for Clindamycin imports from India, with a total trade value of $3.7M across 4 shipments — representing a 4.0% share of all Clindamycin exports. The average shipment value of $912.8K is above the global average of $12.5K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Clindamycin importers in Philippines: NELPA LIFESCIENCES INC is the largest buyer, accounting for 58.0% ($2.1M) of this market's total imports.

• NELPA LIFESCIENCES INC — $2.1M (58.0% of Philippines's total)

Key Insight: Philippines's per-shipment average of $912.8K (7225% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Philippines is a key market for Clindamycin imports from India.

Primary Market

Secondary Market

4Myanmar

Myanmar ranks as the fourth-largest destination for Clindamycin imports from India, with a total trade value of $3.1M across 3 shipments — representing a 3.4% share of all Clindamycin exports. The average shipment value of $1.0M is above the global average of $12.5K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Clindamycin importers in Myanmar: LEGEND CREATIVES CO. LTD. is the largest buyer, accounting for 97.2% ($3.0M) of this market's total imports.

• LEGEND CREATIVES CO. LTD. — $3.0M (97.2% of Myanmar's total)

Key Insight: Myanmar's per-shipment average of $1.0M (8174% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Myanmar is a key market for Clindamycin imports from India.

Primary Market

Secondary Market

5Canada

Canada ranks as the fifth-largest destination for Clindamycin imports from India, with a total trade value of $2.1M across 0 shipments — representing a 2.3% share of all Clindamycin exports. The average shipment value of $2.1M is above the global average of $12.5K, indicating high-value procurement contracts or branded formulations.

Key Insight: Canada's per-shipment average of $2.1M (16902% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Canada is a key market for Clindamycin imports from India.

Primary Market

Secondary Market

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Clindamycin.
2.Flow Mapping: 527 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
3.Value Aggregation: Trade value per supplier-buyer link aggregated from 7,242 individual shipment records. Values are FOB in USD.
4.Geographic Clustering: Buyer networks clustered across 144 destination countries to identify geographic concentration patterns.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

7,242 Verified Shipments

527 manufacturers in network

Expert-Reviewed

By pharmaceutical trade specialists

Clindamycin

Clindamycin

Who Supplies Clindamycin? Top Manufacturers & Their Global Buyers

🏭 Market Analysis: Top Suppliers & Customer Networks

Clindamycin — Export Intelligence Video

Market Intelligence

Official References & Regulatory Resources

Who Supplies Clindamycin? Top Manufacturers & Their Buyers

Supplier-Customer Network Analysis

Clindamycin Supplier Network — Key Market Intelligence

Market Analysis: Top Suppliers & Their Customer Networks

1ENCUBE ETHICALS PRIVATE LIMITED

2AUROBINDO PHARMA LTD

3AUROBINDO PHARMA LIMITED

4MICRO LABS LIMITED

5BIOMATRIX HEALTHCARE PRIVATE LIMITED

6GLENMARK PHARMACEUTICALS LIMITED

From Indian Factories to Global Pharmacies — How Clindamycin Flows

🌍 Market Analysis: Top Importing Countries & Importers

Where Does Clindamycin Go? Top Importing Countries & Their Buyers

Geographic Market Flow Analysis

Market Analysis: Top Importing Countries & Their Importers

1United States

2Kenya

3Philippines

4Myanmar

5Canada

People Also Ask — Clindamycin Supplier & Trade Network

Clindamycin Trade Network — Key Takeaways

Network Overview

Supplier Network

Country Network

Network Insights

Related Analysis

Network Intelligence

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology